Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Quentin Le Hingrat and Benoit Visseaux.
Connection Strength

3.832
  1. Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France. Influenza Other Respir Viruses. 2021 07; 15(4):425-428.
    View in: PubMed
    Score: 0.938
  2. Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads. J Virol Methods. 2018 07; 257:12-15.
    View in: PubMed
    Score: 0.761
  3. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection. J Infect Dis. 2021 05 20; 223(9):1522-1527.
    View in: PubMed
    Score: 0.237
  4. Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. Int J Infect Dis. 2021 Jun; 107:179-181.
    View in: PubMed
    Score: 0.235
  5. Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements. J Virol Methods. 2021 05; 291:114086.
    View in: PubMed
    Score: 0.232
  6. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection. J Clin Microbiol. 2020 Jul 23; 58(8).
    View in: PubMed
    Score: 0.223
  7. Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection. J Clin Virol. 2020 08; 129:104520.
    View in: PubMed
    Score: 0.222
  8. High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings. J Clin Virol. 2021 08; 141:104895.
    View in: PubMed
    Score: 0.060
  9. Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection in Blood of Critically Ill Patients. Clin Infect Dis. 2021 05 18; 72(10):e690-e691.
    View in: PubMed
    Score: 0.059
  10. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
    View in: PubMed
    Score: 0.058
  11. Correction: Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department. PLoS One. 2021; 16(1):e0246458.
    View in: PubMed
    Score: 0.058
  12. Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department. PLoS One. 2020; 15(12):e0243261.
    View in: PubMed
    Score: 0.057
  13. Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity". Antimicrob Agents Chemother. 2020 11 17; 64(12).
    View in: PubMed
    Score: 0.057
  14. Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrob Agents Chemother. 2020 10 20; 64(11).
    View in: PubMed
    Score: 0.057
  15. SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients. Crit Care. 2020 10 16; 24(1):610.
    View in: PubMed
    Score: 0.057
  16. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott). J Clin Virol. 2020 11; 132:104618.
    View in: PubMed
    Score: 0.056
  17. Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. J Antimicrob Chemother. 2020 09 01; 75(9):2657-2660.
    View in: PubMed
    Score: 0.056
  18. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report. J Antimicrob Chemother. 2020 09 01; 75(9):2706-2707.
    View in: PubMed
    Score: 0.056
  19. Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2. J Clin Virol. 2020 Sep; 130:104573.
    View in: PubMed
    Score: 0.056
  20. Case report study of the first five COVID-19 patients treated with remdesivir in France. Int J Infect Dis. 2020 Sep; 98:290-293.
    View in: PubMed
    Score: 0.056
  21. HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man. Open Forum Infect Dis. 2018 Oct; 5(10):ofy223.
    View in: PubMed
    Score: 0.049
  22. Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58. J Infect Dis. 2018 08 24; 218(7):1027-1036.
    View in: PubMed
    Score: 0.049
  23. Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants. PLoS One. 2018; 13(6):e0198334.
    View in: PubMed
    Score: 0.048
  24. Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients. J Antimicrob Chemother. 2018 05 01; 73(5):1173-1176.
    View in: PubMed
    Score: 0.048
  25. Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients. J Antimicrob Chemother. 2017 10 01; 72(10):2954-2955.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.